TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner
暂无分享,去创建一个
M. Emerman | J. Luban | E. Campbell | Kyusik Q Kim | M. Ohainle | Abby Felton | Sevnur Komurlu Keceli
[1] T. Hope,et al. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid , 2019, Journal of Virology.
[2] O. Pornillos,et al. Restriction of HIV-1 and other retroviruses by TRIM5 , 2019, Nature Reviews Microbiology.
[3] M. Malim,et al. Immunoproteasome activation enables human TRIM5α restriction of HIV-1 , 2019, Nature Microbiology.
[4] Barbara Müller,et al. HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex , 2019, eLife.
[5] A. Brass,et al. Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. , 2018, Cell host & microbe.
[6] P. Bieniasz,et al. Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2 , 2018, eLife.
[7] J. Delrow,et al. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV , 2018, bioRxiv.
[8] A. Engelman,et al. Capsid-Dependent Host Factors in HIV-1 Infection. , 2017, Trends in microbiology.
[9] J. Luban,et al. Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines , 2017, Nature Communications.
[10] A. Engelman,et al. Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo , 2016, Journal of Virology.
[11] M. Malim,et al. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors , 2016, Journal of Virology.
[12] A. Engelman,et al. The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes* , 2016, The Journal of Biological Chemistry.
[13] A. Engelman,et al. A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin , 2016, Proceedings of the National Academy of Sciences.
[14] T. Hope,et al. HIV-1 capsid: the multifaceted key player in HIV-1 infection , 2015, Nature Reviews Microbiology.
[15] L. James,et al. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry , 2015, Journal of Virology.
[16] Zhenlong Liu,et al. The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB , 2015, Retrovirology.
[17] Jun S. Liu,et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.
[18] T. Hope,et al. Identification of Capsid Mutations That Alter the Rate of HIV-1 Uncoating in Infected Cells , 2014, Journal of Virology.
[19] P. Bieniasz,et al. Host and Viral Determinants of Mx2 Antiretroviral Activity , 2014, Journal of Virology.
[20] C. Aiken,et al. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. , 2014, Virology.
[21] G. Towers,et al. A model for cofactor use during HIV-1 reverse transcription and nuclear entry☆ , 2014, Current opinion in virology.
[22] D. Ivanov,et al. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction. , 2014, Virology.
[23] C. Aiken,et al. In Vivo Functions of CPSF6 for HIV-1 as Revealed by HIV-1 Capsid Evolution in HLA-B27-Positive Subjects , 2014, PLoS pathogens.
[24] L. James,et al. HIV-1 evades innate immune recognition through specific co-factor recruitment , 2013, Nature.
[25] Shilei Ding,et al. The interferon-inducible MxB protein inhibits HIV-1 infection. , 2013, Cell host & microbe.
[26] Charles M. Rice,et al. MX2 is an interferon-induced inhibitor of HIV-1 infection , 2013, Nature.
[27] M. Malim,et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection , 2013, Nature.
[28] A. Engelman,et al. The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating , 2012, Journal of Virology.
[29] Michael Emerman,et al. Evolutionary conflicts between viruses and restriction factors shape immunity , 2012, Nature Reviews Immunology.
[30] Torsten Schaller,et al. CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication , 2012, PLoS pathogens.
[31] M. Malim,et al. HIV Restriction Factors and Mechanisms of Evasion. , 2012, Cold Spring Harbor perspectives in medicine.
[32] A. Engelman,et al. Human Immunodeficiency Virus Type 1 Capsid Mutation N74D Alters Cyclophilin A Dependence and Impairs Macrophage Infection , 2012, Journal of Virology.
[33] J. Luban,et al. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus , 2011, Retrovirology.
[34] Mahdad Noursadeghi,et al. HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency , 2011, PLoS pathogens.
[35] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[36] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[37] J. Sodroski,et al. Determinants of the Higher Order Association of the Restriction Factor TRIM5α and Other Tripartite Motif (TRIM) Proteins* , 2011, The Journal of Biological Chemistry.
[38] Jeremy Luban,et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.
[39] J. Nieman,et al. HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention , 2010, PLoS pathogens.
[40] R. Schooley,et al. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. , 2010, The Journal of infectious diseases.
[41] A. Engelman,et al. Flexible use of nuclear import pathways by HIV-1. , 2010, Cell host & microbe.
[42] Michael Emerman,et al. Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals , 2007, PLoS pathogens.
[43] J. Sodroski,et al. Unique features of TRIM5α among closely related human TRIM family members , 2007 .
[44] P. Bieniasz,et al. Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion , 2006, Science.
[45] D. Pérez-Caballero,et al. Antiretroviral potential of human tripartite motif-5 and related proteins. , 2006, Virology.
[46] S. Nisole,et al. TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.
[47] Michael Emerman,et al. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Emerman,et al. Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells , 2004, Journal of Virology.
[49] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[50] A Orimo,et al. Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. , 2000, Genomics.
[51] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[52] Jeremy Luban,et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.
[53] T. Sultana,et al. Multiple pathways to avoid IFN-β sensitivity of HIV-1 by mutations in capsid , 2019 .
[54] J. Sodroski,et al. Unique features of TRIM5alpha among closely related human TRIM family members. , 2007, Virology.